TLR2 and Parkinson disease: In particular, cells stimulated with RQ-MSA showed a significantly higher expression levels for TLR2 (RQ-MSA vs. RQ-no seed: p = 0.005; RQ-MSA vs. RQ-PD: p = 0.01) (Figure 3A), TRAF6 (RQ-MSA vs. RQ-no seed: p < 0.0001; RQ-MSA vs. RQ-PD: p < 0.0001) (Figure 3C), IL6 (RQ-MSA vs. RQ-no seed: p = 0.008; RQ-MSA vs. RQ-PD: p = 0.001) (Figure 3D), NLRP3 (RQ-MSA vs. RQ-no seed: p = 0.008; RQ-MSA vs. RQ-PD: p = 0.003) (Figure 3E), and SOD2 (RQ-MSA vs. RQ-no seed: p = 0.01; RQ-MSA vs. RQ-PD: p = 0.0042) (Figure 3F) than those stimulated with RQ-PD and RQ-no seed.